HomeInsightsStock Comparison

Abbott India Ltd vs Glenmark Pharmaceuticals Ltd Stock Comparison

Abbott India Ltd vs Glenmark Pharmaceuticals Ltd Stock Comparison

Last Updated on: Dec 20, 2025

Key Highlights

  • The Latest Trading Price of Abbott India Ltd is ₹ 28300 as of 09 Dec 12:23.
  • The P/E Ratio of Abbott India Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Glenmark Pharmaceuticals Ltd changed from 7.5 on March 2020 to 41.5 on March 2025 . This represents a CAGR of 32.99% over 6 years.
  • The Market Cap of Abbott India Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Glenmark Pharmaceuticals Ltd changed from ₹ 5814 crore on March 2020 to ₹ 43458 crore on March 2025 . This represents a CAGR of 39.83% over 6 years.
  • The revenue of Abbott India Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Glenmark Pharmaceuticals Ltd for the Sep '25 is ₹ 6247 crore as compare to the Jun '25 revenue of ₹ 3290 crore. This represent the growth of 89.84%.
  • The ebitda of Abbott India Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Glenmark Pharmaceuticals Ltd for the Sep '25 is ₹ 1175 crore as compare to the Jun '25 ebitda of ₹ 283.73 crore. This represent the growth of 314.15%.
  • The net profit of Abbott India Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The net profit of Glenmark Pharmaceuticals Ltd changed from ₹ 173.13 crore to ₹ 610.43 crore over 10 quarters. This represents a CAGR of 65.54% .
  • The Dividend Payout of Abbott India Ltd changed from 89.6 % on March 2020 to 71.36 % on March 2025 . This represents a CAGR of -3.72% over 6 yearsThe Dividend Payout of Glenmark Pharmaceuticals Ltd changed from 5.21 % on March 2020 to 4.38 % on March 2025 . This represents a CAGR of -2.85% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Abbott India Ltd

  • Abbott India Ltd. is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.
  • The Company sells its products through independent distributors primarily within India.
  • It provides products and solutions across various therapeutic areas such as Women's Health, Gastroenterology, Central Nervous System, Metabolics, Multi-Specialty, Vaccines, Consumer Health, etc.
  • Its global products include Brufen, Prothiaden, Thyronorm and Leptos. The company has four divisions.
  • The Primary Care division markets products in the areas of pain management and gastroenterology.

About Glenmark Pharmaceuticals Ltd

  • Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977.
  • The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
  • It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets.
  • The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities are located at Nasik, Colvale, Baddi, Nalagarh, Sikkim, Indore and Aurangabad in India. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
  • Its branded generics business has a significant presence in markets across emerging economies including India.

Abbott India Ltd News Hub

News

Abbott India gets central govt nod to appoint Kartik Rajendran as MD

His tenure will be for a period of five years, effective from 14 June 2025, to 13 June 203...

Read more

25 Nov 2025 11:22

News

Abbott India receives Central Govt. approval for appointment of MD

Abbott India has received approval from the Central Government under Section 196 of the Co...

Read more

24 Nov 2025 18:28

News

Abbott India Q2 PAT jumps 16% YoY to Rs 415 cr

Profit before tax (PBT) stood at Rs 545.93 crore in Q2 FY26, up 13.87% year on year (YoY)....

Read more

06 Nov 2025 15:40

News

Abbott India to hold board meeting

Abbott India will hold a meeting of the Board of Directors of the Company on 6 November 20...

Read more

30 Oct 2025 10:39

News

Abbott India Ltd up for third straight session

Abbott India Ltd is up for a third straight session today. The stock is quoting at Rs 3050...

Read more

06 Oct 2025 13:05

News

Abbott India rises as Q1 PAT jumps 12% YoY to Rs 366 cr

Profit before tax (PBT) stood at Rs 493.13 crore in Q1 FY26, up 12.78% year on year (YoY)....

Read more

12 Aug 2025 13:50

Glenmark Pharmaceuticals Ltd News Hub

News

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session

Glenmark Pharmaceuticals Ltd is up for a fifth straight session today. The stock is quotin...

Read more

15 Dec 2025 13:00

News

Glenmark USA to launch Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the upcoming launch of Leucovorin ...

Read more

11 Dec 2025 09:08

News

Glenmark Pharma's U.S. arm to launch Leucovorin Calcium Injection in the U.S. Market

The product is bioequivalent and therapeutically equivalent to the reference listed drug (...

Read more

11 Dec 2025 11:55

News

Glenmark's Aurangabad unit completes USFDA inspection

Glenmark Pharmaceuticals announced that the U.S. Food and Drug Administration (U.S. FDA) c...

Read more

01 Dec 2025 09:14

News

Glenmark Pharma's Chhatrapati Sambhajinagar facility clears USFDA inspection with zero observations

According to the company's exchange filing, the inspection was conducted between 24 Novemb...

Read more

01 Dec 2025 10:37

News

Glenmark's Monroe facility concludes USFDA inspection

Glenmark Pharmaceuticals has received Establishment Inspection Report (EIR) with a Volunta...

Read more

27 Nov 2025 10:43

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

SWOT Analysis Of Abbott India Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Glenmark Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Abbott India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Abbott India Ltd and Glenmark Pharmaceuticals Ltd

Which company has a larger market capitalization, Abbott India Ltd or Glenmark Pharmaceuticals Ltd?

Market cap of Abbott India Ltd is 59,583 Cr while Market cap of Glenmark Pharmaceuticals Ltd is 56,179 Cr

What are the key factors driving the stock performance of Abbott India Ltd and Glenmark Pharmaceuticals Ltd?

The stock performance of Abbott India Ltd and Glenmark Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Abbott India Ltd and Glenmark Pharmaceuticals Ltd?

As of December 20, 2025, the Abbott India Ltd stock price is INR ₹28039.3. On the other hand, Glenmark Pharmaceuticals Ltd stock price is INR ₹1990.75.

How do dividend payouts of Abbott India Ltd and Glenmark Pharmaceuticals Ltd compare?

To compare the dividend payouts of Abbott India Ltd and Glenmark Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions